Dimitrios (Dimitri) Strepkos, MD

Center for Coronary Artery Disease International Scholar

Dimitrios (Dimitri) Strepkos, MD joined the Center of Coronary Artery Disease as an International Research Scholar. In his role, Dimitri will work on various CCAD IIS projects, including REBIRTH, NASA, PROGRESS-CTO, CARE-CTO, PROGRESS Bifurcations, PROGRESS Complications, among others.

Dr. Strepkos was born and raised in Athens, Greece where he obtained his MD with honors from the National and Kapodistrian University of Athens in 2022. When he graduated from high school, he received the Eurobank scholarship award for his exemplary academic performance by scoring the highest in the Greek University entrance exams. During his time in medical school, Dr. Strepkos was heavily involved in basic science research and published a number of articles before graduating. He also developed a special interest in cardiology and devoted the summer of his 5th year of medical school to working with the 1st Department of Cardiology in the Hippokrateion University Hospital of Athens. 

Dr. Strepkos has also devoted two months in elective rotations in the Cardiology Department of the Johns Hopkins University Hospital. After he finished medical school, he worked as an Internal Medicine resident in the Thriassio General Hospital of Elefsina for 1.5 years.

Back to Coronary Team Back to Current Scholars

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute FoundationĀ® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.